SCHEMBL14103803

SCHEMBL14103803

COc1ccc(-c2nc(Oc3c(F)cccc3F)c3sccc3n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.49
▸ HTT P42858 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 5/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CYP1A1 P04798 1/20 0.38
▸ CYP1B1 Q16678 1/20 0.38
▸ SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14104444 0.86 PIK3CA (0.42) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14103889 0.83 CTSA (0.36) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14103797 0.82 HTT (0.47) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL9881233 0.82 CYP1A2 (0.61) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14104174 0.81 HTT (0.60) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14103805 0.80 KDM4E (0.41) GAAKDM4EMAPTTP53SMN1; SMN2
SCHEMBL14103767 0.78 HTT (0.43) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14103807 0.77 JAK3 (0.49) NPC1RAB9ASYK
SCHEMBL14104181 0.77 RXFP1 (0.55) CYP1A2HTTCYP3A4CYP2C9CYP2C19
SCHEMBL14103890 0.75 ABCG2 (0.36) CYP1A2HTTCYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback